Ozempic 0.25-0.5 MG/dose pen 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCZ3Z
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,634
Award facts
- Contract value 100% obligated
- $15,633.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,633.89 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL formulations. This firm fixed-price, competitively awarded contract—with no set-aside designation—is scheduled for completion by January 14, 2026, just one day after the award date of January 13, 2026. The work is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs across multiple therapeutic domains, including diabetes care products like those specified in this delivery order.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends through December 2026. That overarching contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of medications and medical supplies to support military healthcare programs worldwide. The parent company, Cencora, Inc., maintains an even larger IDC with the DLA valued at up to $999,999,999.00 through December 31, 2031, reflecting the company's significant role in the federal pharmaceutical supply chain for the Department of Defense and military healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FCZ3Z?
SPE2DR26FCZ3Z was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FCZ3Z worth?
The government has obligated $15,634 on SPE2DR26FCZ3Z.
Is contract SPE2DR26FCZ3Z an order under another contract?
Yes. SPE2DR26FCZ3Z is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCZ3Z competed?
The extent of competition for SPE2DR26FCZ3Z was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award